MR编号 | CZ/H/0233/004 |
---|
药品名称 | VALSACOMBI 320 MG/12,5 MG |
---|
活性成分 | - hydrochlorothiazide 12.5 mg
- valsartan 320.0 mg
|
---|
剂型 | Film-coated tablet |
---|
上市许可持有人 | Krka d.d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia |
---|
参考成员国 - 产品名称 | Czechia (CZ) sukls149972/2013 |
---|
互认成员国 - 产品名称 | - Germany (DE)
Valsartan/Hydrochlorothiazid TAD 320 mg/12,5 mg Filmtabletten - Denmark (DK)
- Ireland (IE)
- Austria (AT)
Valsartan/Hydrochlorothiazid Krka 320 mg/12,5 mg Filmtabletten - Spain (ES)
- Greece (GR)
- Sweden (SE)
Valsartan/Hydrochlorothiazide Krka - Norway (NO)
- Finland (FI)
- Poland (PL)
Co-Valsacor - Latvia (LV)
- Lithuania (LT)
Valsacombi 320 mg/12,5 mg plėvele dengtos tabletės - Estonia (EE)
VALSACOMBI - Hungary (HU)
CO-VALSACOR 320 mg/12,5 mg filmtabletta - Bulgaria (BG)
Co-Valsacor - Slovenia (SI)
- Slovakia (SK)
Co-Valsacor 320 mg/12,5 mg filmom obalené tablety
|
---|
许可日期 | 2010/11/15 |
---|
最近更新日期 | 2024/02/20 |
---|
药物ATC编码 | - C09DA03 valsartan and diuretics
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|
|
---|